Walgreens Specialty Pharmacy highlighted results from its specialty oncology support model, including a reported 92% medication adherence rate versus an 80% industry benchmark, and framed the program as beyond traditional oncology dispensing. The Specialty360 approach pairs oncology-trained pharmacists and other support roles to manage therapy complexity that patients navigate at home. The report describes integrated support across adherence, comorbidities, and financial barriers, citing example patient scenarios involving oral therapies and multi-medication burden. It also claims access via a multichannel specialty pharmacy network. For industry stakeholders, the key point is that care delivery infrastructure—nurse and pharmacist-led, benefits-focused, and multichannel—has become a competitive lever in oncology as regimens become more patient-managed and chronic.